A new study has given leukemia researchers a powerful new dataset and collection of analytical methods—and a starting point for future research. One common treatment for leukemia is hematopoietic stem ...
EMBL scientists discovered self-sustaining inflammatory circuits in the bone marrow stem cell microenvironment that precede blood cancers. The illustration shows cancer cells against a background of ...
Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by BCR-ABL1 gene fusion. The immune microenvironment, implicated in relapse and drug resistance, poses significant challenges ...
Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...
Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy. A team of researchers from Colombia Engineering and Irving Institute for Cancer ...
Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by BCR-ABL1 gene fusion. The immune microenvironment, implicated in relapse and drug resistance, poses significant challenges ...
In a recently published study, researchers at Fox Chase Cancer Center revealed for the first time that cancer cells can evade anti-cancer drugs by entering and surviving within bone marrow fibroblasts ...
Mar. 23 -- FRIDAY, June 15 (HealthDay News) -- Defects in bone marrow can lead to abnormal blood cells that cause precancerous blood diseases in mice, two new studies find. Blood cells are produced in ...
Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Without even thinking about it, the bone marrow in your body is ...
From the Damian Green Lab, in collaboration with the Geoff Hill and Riddell Labs, Translational Sciences and Therapeutics Division and David Coffey, Division of Myeloma, at the University of Miami To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results